Ackermans & Van Haaren N.V.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Piet Dejonghe
- Full Time Employees
- 24,931
- Sector
- Industrials
- Industry
- Engineering & Construction
- Address
- Begijnenvest 113 Antwerp BU Belgium 2000
- IPO Date
- Jan 2, 2014
- Website
- avh.be
- Similar Companies
- Business
- Ackermans & Van Haaren NV is a diversified Belgian investment holding company that develops and manages a concentrated portfolio of strategic participations across marine engineering and contracting; private banking; real estate and senior care; energy and resources; and growth capital. Founded in 1876 and headquartered in Antwerp, Belgium, the company operates globally through key subsidiaries and associates, including DEME Group NV, a global leader in dredging, marine construction, offshore energy infrastructure, and environmental solutions; CFE NV, a construction and real estate development group specializing in complex infrastructure, industrial projects, and property development; Delen Private Bank NV, one of Belgium's largest independent private asset managers offering discretionary portfolio management, advisory services, and wealth planning primarily to high-net-worth individuals, entrepreneurs, and liberal professionals in Belgium, the Netherlands, and the United Kingdom through its JM Finn subsidiary; Bank J. Van Breda & Co NV, a niche bank providing tailored banking, financing, insurance, and asset management solutions for entrepreneurs and liberal professions in Belgium; Nextensa SA, a listed integrated real estate developer and manager focused on residential, office, retail, and logistics properties primarily in Belgium, Luxembourg, and select European markets; SIPEF NV, an agro-industrial group engaged in sustainable tropical agriculture, including the cultivation and processing of palm oil, bananas, natural rubber, tea, and coffee across plantations in Southeast Asia, Africa, and South America; and various growth capital investments in high-potential family-controlled companies spanning sectors such as technology, healthcare, and consumer goods. The group's activities employ over 24,000 people worldwide and generate consolidated turnover exceeding EUR 6 billion, with significant exposure to international markets in Europe, Asia, Africa, the Americas, and the Middle East. In recent developments, Ackermans & Van Haaren participated in a STAR Capital-led consortium that completed the acquisition of V.Group, a leading global provider of mission-critical maritime support services including crewing, technical management, and digital solutions, with AvH's investment valued at approximately USD 150 million in September 2024; invested EUR 22 million in VKC Nuts Private Limited, a prominent Indian family-owned cashew processing company, in September 2025 to support expansion in sustainable nut processing; strengthened its long-term partnership with the Delen family through updated shareholder arrangements for Delen Private Bank and Bank J. Van Breda & Co; reported outstanding first-quarter 2024 results at DEME and its private banks, confirming full-year net profit guidance exceeding 2023 levels; and maintains significant stakes such as 62% in DEME, 41% in SIPEF, and 63% in Nextensa, while pursuing activist strategies in growth-oriented participations amid strong market performance including analyst upgrades from Oddo BHF and Berenberg in 2025.
Ackermans & van Haaren: all items on the agenda of the ASM approved, incl. gross dividend of €4.60 per share
Ackermans & van Haaren (Trading Update Q1 2026): Strong start to the year of core participations. Confirmation of guidance.
Ackermans & van Haaren ends a successful year 2025 with a net profit of 593 million euros (+29%)
Ackermans & van Haaren Trading Update 3Q2025: Excellent results of core participations, FY2025 Outlook confirmed
Ackermans & van Haaren invests 22 million euros in VKC Nuts
Ackermans & van Haaren supports MRM Health's Series B financing round of 55 million euros
Ackermans & van Haaren commits 20 million US dollars to the second fund of Venturi Partners
Ackermans & van Haaren: First-Half 2025 Results
Ackermans & van Haaren: the General Shareholders' Meeting approves all proposed resolutions by a vast majority
Ackermans & van Haaren (Trading Update Q1 2025): AvH reports solid start to the year and confirms guidance
Ackermans & van Haaren: publication of a transparency notification
Ackermans & van Haaren grows net profit by 15% in 2024 to 460 million euros.
Ackermans & van Haaren Trading Update Q3 2024 - AvH is on track towards a net profit well above 400 million euros
Ackermans & van Haaren and the Delen family confirm their long-term partnership with updated shareholder arrangements in respect of Delen Private Bank and Bank J. Van Breda & Co
Ackermans & van Haaren invests an additional 5 million euros in Biotalys
Ackermans & van Haaren: Outstanding results in core participations result in a strong increase of AvH's net profit for 1H2024 to EUR 200 million (+17%)
Ackermans & van Haaren leads EUR 60 million Series B Financing Round for Confo Therapeutics, a Belgian clinical-stage biopharmaceutical company
Ackermans & van Haaren: the General Shareholders' Meeting approves all proposed resolutions by a large majority
Ackermans & van Haaren reports outstanding Q1-results at both DEME and at the private banks Delen and Van Breda, and gives confirmation of guidance: net profit of 2024 expected to be higher than last year
Ackermans & van Haaren realised a net profit of 399.2 million euros, thanks to a record performance of its core participations